1. Home
  2. SWTX vs ABR Comparison

SWTX vs ABR Comparison

Compare SWTX & ABR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • ABR
  • Stock Information
  • Founded
  • SWTX 2017
  • ABR 2003
  • Country
  • SWTX United States
  • ABR United States
  • Employees
  • SWTX N/A
  • ABR N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • ABR Real Estate Investment Trusts
  • Sector
  • SWTX Health Care
  • ABR Real Estate
  • Exchange
  • SWTX Nasdaq
  • ABR Nasdaq
  • Market Cap
  • SWTX 3.0B
  • ABR 2.6B
  • IPO Year
  • SWTX 2019
  • ABR 2004
  • Fundamental
  • Price
  • SWTX $58.25
  • ABR $12.00
  • Analyst Decision
  • SWTX Strong Buy
  • ABR Hold
  • Analyst Count
  • SWTX 6
  • ABR 6
  • Target Price
  • SWTX $70.83
  • ABR $14.00
  • AVG Volume (30 Days)
  • SWTX 3.2M
  • ABR 3.4M
  • Earning Date
  • SWTX 02-20-2025
  • ABR 02-21-2025
  • Dividend Yield
  • SWTX N/A
  • ABR 14.33%
  • EPS Growth
  • SWTX N/A
  • ABR N/A
  • EPS
  • SWTX N/A
  • ABR 1.18
  • Revenue
  • SWTX $191,589,000.00
  • ABR $553,580,000.00
  • Revenue This Year
  • SWTX $3,475.18
  • ABR N/A
  • Revenue Next Year
  • SWTX $81.60
  • ABR N/A
  • P/E Ratio
  • SWTX N/A
  • ABR $10.17
  • Revenue Growth
  • SWTX 3417.33
  • ABR N/A
  • 52 Week Low
  • SWTX $28.21
  • ABR $11.87
  • 52 Week High
  • SWTX $62.00
  • ABR $15.94
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 70.71
  • ABR 22.95
  • Support Level
  • SWTX $54.89
  • ABR $13.61
  • Resistance Level
  • SWTX $62.00
  • ABR $13.91
  • Average True Range (ATR)
  • SWTX 4.09
  • ABR 0.42
  • MACD
  • SWTX 1.35
  • ABR -0.08
  • Stochastic Oscillator
  • SWTX 85.90
  • ABR 5.19

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About ABR Arbor Realty Trust

Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment. The company is externally managed and advised by Arbor Commercial Mortgage, LLC.

Share on Social Networks: